| 1 | Diagnostic Performance of Non-invasive Fibrosis Indexes in H… (10.4274/vhd.galenos.2020.2019.0038) | Abstract References License | 67.73 | 7 |
| 2 | Distribution of Hepatitis C Virus Genotypes in Aydın Provinc… (10.4274/vhd.2018.0019) | Abstract References License | 63.38 | 6 |
| 3 | Hepatitis B Virus Infection: Knowledge and Awareness Among t… (10.4274/vhd.galenos.2018.0016) | Abstract References License | 63.38 | 6 |
| 4 | Distribution of Hepatitis C Virus Genotypes: 18-Year Experie… (10.4274/vhd.galenos.2021.2021-6-2) | Abstract References License | 63.38 | 6 |
| 5 | Genotyping Distribution of Hepatitis C Virus in Şanlıurfa Pr… (10.4274/vhd.galenos.2019.2019.0012) | Abstract References License | 58.36 | 5 |
| 6 | Genotype Distribution of Hepatitis C Virus and Demographic F… (10.4274/vhd.galenos.2020.2020-0022) | Abstract References License | 58.36 | 5 |
| 7 | Seroprevalence of HBsAg and Anti-HCV among HIV Positive Pati… (10.4274/vhd.galenos.2020.2019.0043) | Abstract References License | 52.42 | 4 |
| 8 | Long-Term Outcomes of Patients with Chronic Hepatitis C Trea… (10.4274/vhd.galenos.2024.2024-5-2) | Abstract ORCID License | 52.42 | 4 |
| 9 | Frequency of Hepatitis Delta Virus in Hepatitis B Surfaceant… (10.4274/vhd.galenos.2018-0018) | Abstract References License | 45.15 | 3 |
| 10 | An Evaluation of Hepatitis B Virus and Hepatitis C Virus Fre… (10.4274/vhd.galenos.2019.2019.0033) | Abstract References License | 45.15 | 3 |
| 11 | Genotype Distribution of Hepatitis C Virus in Hatay Province… (10.4274/vhd.galenos.2020.2020.0009) | Abstract References License | 45.15 | 3 |
| 12 | Intravenous Drug Use Rates and Results of Direct-acting Anti… (10.4274/vhd.galenos.2020.2020.0015) | Abstract References License | 45.15 | 3 |
| 13 | Evaluation of Treatment Results with Direct Acting Antiviral… (10.4274/vhd.galenos.2020.2020.0016) | Abstract References License | 45.15 | 3 |
| 14 | An Evaluation of Health Personnel Exposed to Occupational In… (10.4274/vhd.galenos.2020.2020.0024) | Abstract References License | 45.15 | 3 |
| 15 | Results of Viral Hepatitis and Human Immunodeficiency Virus… (10.4274/vhd.galenos.2021.2020-12-8) | Abstract References License | 45.15 | 3 |
| 16 | Demographic Characteristics and Transmission Risk Factors of… (10.4274/vhd.galenos.2021.2021-1-3) | Abstract References License | 45.15 | 3 |
| 17 | Eliminating Viral Hepatitis in Turkey: Achievements and Chal… (10.4274/vhd.galenos.2022.2022-9-1) | Abstract License | 45.15 | 7 |
| 18 | Circulating Glucose-Regulated Protein 78 Levels in Patients… (10.4274/vhd.2018.0011) | Abstract References License | 35.78 | 2 |
| 19 | Relationship Between Basic Laboratory Results and Fibrosis i… (10.4274/vhd.galenos.2019.2019.0010) | Abstract References License | 35.78 | 2 |
| 20 | Direct-acting Antiviral Therapy for Mixed Genotype Chronic H… (10.4274/vhd.galenos.2019.2019.0013) | Abstract References License | 35.78 | 2 |
| 21 | The Evaluation of the Relation Between Drug Compliance and P… (10.4274/vhd.galenos.2019.2019.0021) | Abstract References License | 35.78 | 2 |
| 22 | Efficacy of Direct-acting Antivirals in Hemodialysis Patient… (10.4274/vhd.galenos.2019.2019.0025) | Abstract References License | 35.78 | 2 |
| 23 | Evaluation of Signal/Cut-off Ratio by Anti-hepatitis Delta V… (10.4274/vhd.galenos.2019.2019.0026) | Abstract References License | 35.78 | 2 |
| 24 | Hepatitis B Surface Antigen Seroprevalence of Turkish and Fo… (10.4274/vhd.galenos.2019.2019.0034) | Abstract References License | 35.78 | 2 |
| 25 | Evaluation of Hepatitis A Seroprevalance and Epidemiologic D… (10.4274/vhd.galenos.2020.2019.0037) | Abstract References License | 35.78 | 2 |
| 26 | HBV Flare Under Tenofovir Treatment in Chronic Hepatitis B:… (10.4274/vhd.galenos.2020.2020.0005) | Abstract References License | 35.78 | 2 |
| 27 | Evaluation of Health-Related Life Quality of Patients with C… (10.4274/vhd.galenos.2020.2020.0011) | Abstract References License | 35.78 | 2 |
| 28 | Investigating Hepatitis C, D and HIV Prevalance in Cases wit… (10.4274/vhd.galenos.2020.2020.0014) | Abstract References License | 35.78 | 2 |
| 29 | Investigating the Prevalence of Hepatitis Delta and Assessme… (10.4274/vhd.galenos.2020.2020.0025) | Abstract References License | 35.78 | 2 |
| 30 | Frequency of HBV, HCV and HIV Infections and Determination o… (10.4274/vhd.galenos.2021.2020-12-6) | Abstract References License | 35.78 | 2 |
| 31 | Genotype Distributions and Hepatitis B Coinfection in Hepati… (10.4274/vhd.galenos.2021.2021-1-1) | Abstract References License | 35.78 | 2 |
| 32 | Hepatitis C Coinfection Among People Living with HIV in a Un… (10.4274/vhd.galenos.2021.2021-1-4) | Abstract References License | 35.78 | 2 |
| 33 | Insulin Resistance in Patients with Chronic Hepatitis B Viru… (10.4274/vhd.galenos.2021.2021-2-6) | Abstract References License | 35.78 | 2 |
| 34 | Effect of a Nationwide Universal HBV Vaccination Program and… (10.4274/vhd.galenos.2021.2021-5-7) | Abstract References License | 35.78 | 2 |
| 35 | Comparison of Hepatitis B and Hepatitis C Seropositivity of… (10.4274/vhd.galenos.2022.2020-12-5) | Abstract License | 34.95 | 4 |
| 36 | Relationships Between Liver Histopathology with Biochemical… (10.4274/vhd.galenos.2023.2023-8-2) | Abstract License | 30.10 | 3 |
| 37 | Evaluation of Direct-acting Antiviral Agents and Clinical Re… (10.4274/vhd.galenos.2022.2022-4-2) | Abstract License | 23.86 | 2 |
| 38 | Follow-up, Treatment and Non-invasive Scoring Systems in Chr… (10.4274/vhd.galenos.2023.2022-11-1) | Abstract License | 23.86 | 2 |
| 39 | Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-… (10.4274/vhd.galenos.2023.2023-5-2) | Abstract License | 23.86 | 2 |
| 40 | A New Tool for the Diagnosis and Management of Viral Hepatit… (10.4274/vhd.galenos.2024.2023-12-4) | Abstract License | 23.86 | 2 |
| 41 | Does Pegylated-Interferon Still Have High Efficacy Treatment… (10.4274/vhd.2018.0006) | Abstract References License | 22.58 | 1 |
| 42 | A Misleading Parameter in the Diagnosis of Chronic Hepatitis… (10.4274/vhd.2018.0010) | Abstract References License | 22.58 | 1 |
| 43 | The Epidemiology and Trend of Hepatitis C Infection in Hamad… (10.4274/vhd.2018.0017) | Abstract References License | 22.58 | 1 |
| 44 | Non-hodgkin Lymphoma Developing After Discontinuation of Dir… (10.4274/vhd.galenos.2018.0029) | Abstract References License | 22.58 | 1 |
| 45 | A Comparison of Needle Types and Biopsy Techniques Used in L… (10.4274/vhd.galenos.2018.0030) | Abstract References License | 22.58 | 1 |
| 46 | Impact of Direct Acting Antiviral Agents on Psychiatric and… (10.4274/vhd.galenos.2019.0006) | Abstract References License | 22.58 | 1 |
| 47 | Occult Hepatitis B in Hemodialysis Patients (10.4274/vhd.galenos.2019.2018.0009) | Abstract References License | 22.58 | 1 |
| 48 | The Importance of Antiviral Prophylaxis against Hepatitis B… (10.4274/vhd.galenos.2019.2018.0027) | Abstract References License | 22.58 | 1 |
| 49 | Molecular Characterization of Hepatitis B Virus Strains Isol… (10.4274/vhd.galenos.2019.2019.0015) | Abstract References License | 22.58 | 1 |
| 50 | The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir… (10.4274/vhd.galenos.2019.2019.0028) | Abstract References License | 22.58 | 1 |